Vergleich

MIA PaCa-2 cells

ArtNr C0018002
Hersteller Addexbio
Menge One Frozen vial
Kategorie
Typ Tumour Cells
Specific against Human (Homo sapiens)
Dry ice Yes
Citations 1.Hussein, D. and Mo, H. d-delta-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells. Pancreas, 38: e124-136, 2009.
2.Reigan, P., Colucci, M. A., Siegel, D., Chilloux, A., Moody, C. J., and Ross, D. Development of indolequinone mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1): NQO1 inhibition and growth inhibitory activity in human pancreatic MIA PaCa-2 cancer cells. Biochemistry, 46: 5941-5950, 2007.
3.Kato, S., Shirato, K., Imaizumi, K., Toyota, H., Mizuguchi, J., Odawara, M., Che, X. F., Akiyama, S., Abe, A., and Tomoda, A. Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2. Oncol Rep, 15: 843-848, 2006.
4.Fogli, S., Nieri, P., Chicca, A., Adinolfi, B., Mariotti, V., Iacopetti, P., Breschi, M. C., and Pellegrini, S. Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism. FEBS Lett, 580: 1733-1739, 2006.
5.Roomi, M. W., Ivanov, V., Kalinovsky, T., Niedzwiecki, A., and Rath, M. Antitumor effect of a combination of lysine, proline, arginine, ascorbic acid, and green tea extract on pancreatic cancer cell line MIA PaCa-2. Int J Gastrointest Cancer, 35: 97-102, 2005.
6.Hashimoto, K., Farrow, B. J., and Evers, B. M. Activation and role of MAP kinases in 15d-PGJ2-induced apoptosis in the human pancreatic cancer cell line MIA PaCa-2. Pancreas, 28: 153-159, 2004.
ECLASS 10.1 32160890
ECLASS 11.0 32160890
UNSPSC 41106509
Lieferbar
Description

Disease:

Pancreatic carcinoma

Origin:

An established cell line from an undifferentiated human pancreatic carcinoma

Species:

Homo sapiens

Tissue:

Pancreas

Morphology:

Epithelial

Properties:

Adherent, single cells and loosely attached clusters

Cytogenic data:

Tumorigenic; Modal no. 61; hypotriploid

Patient:

Male, Caucasian, 65 yrs of age

Medium:

AddexBio-formulated DMEM (C0003-01) + 10% FBS

Subculture:

1:3 to 1:6 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C

Freezing Medium:

Complete culture medium supplemented with 5% (v/v) DMSO

Biosafety Level:

I

Sterility:

Bacteria: Negative

Yeast: Negative

Mycoplasma: Negative

Pathogens:

HIV: Negative

Hepatitis B: Negative

Hepatitis C: Negative

Protein Expression:

human colony stimulating factor, subclass I (CSF-I); plasminogen activator

Isoenzymes:

G6PD, B

DNA Profile (STR):

Amelogenin: X CSF1PO: 10 D13S317: 12, 13 D16S539: 10, 13 D5S818: 12, 13 D7S820: 12, 13 THO1: 9, 10 TPOX: 9 vWA: 15

Mutations in MIA PaCa-2 Cells

Related cells by Organ:

AR-42J cells

BxPc-3 cells

Capan-1 cells

MIA PaCa-2 cells

E3LZ10.7 cells

A10.7 cells

INS-1 cells

MIN-6 cells

Storage condition
LN2
Manufacturers Category
Cell Lines

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: One Frozen vial
Lieferbar: In stock
lieferbar

Lieferung vsl. bis 14.03.2025 

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen